PFF

MoneyHero Group Hosts Singapore’s Largest Personal Finance Festival for Seventh Straight Year

Retrieved on: 
木曜日, 4月 11, 2024
Organization, Learning, Ultimate, FWD, Health, PFF, Finance, Personal finance, Insurance, Festival, Convention center, OCBC, Citibank, CIMB, POSB, IPP, Government, POSB Bank, Growth, DBS Bank, Film industry

SINGAPORE, April 11, 2024 (GLOBE NEWSWIRE) -- MoneyHero Limited (NASDAQ: MNY ) (“MoneyHero” or the “Company”), a market leading personal finance and digital insurance aggregation and comparison platform in Greater Southeast Asia, today announced the successful completion of the Company’s seventh annual Seedly Personal Finance Festival (“PFF” or the “Festival”).

Key Points: 
  • SINGAPORE, April 11, 2024 (GLOBE NEWSWIRE) -- MoneyHero Limited (NASDAQ: MNY ) (“MoneyHero” or the “Company”), a market leading personal finance and digital insurance aggregation and comparison platform in Greater Southeast Asia, today announced the successful completion of the Company’s seventh annual Seedly Personal Finance Festival (“PFF” or the “Festival”).
  • The annual Festival, which held its first event in 2018, is produced by Seedly, MoneyHero’s market-leading platform that builds the largest personal finance community in Singapore.
  • Our success is a testament to our enduring mission to serve as the region’s premier resource and advocate in personal finance.
  • Download high-resolution event highlights images here: Seedly Personal Finance Festival 2024
    For more information about MoneyHero, including information for investors and learning about career opportunities, please visit www.MoneyHeroGroup.com .

Broadway Belts for PFF! Extravaganza Raises Voices and Funds for Pulmonary Fibrosis

Retrieved on: 
木曜日, 3月 7, 2024
Come, Infant, PFF, Grammy Awards, City, Future, Ralph Howard, Pulmonary fibrosis, Divinity, Family, The King, Sony Hall, Cagney, Miss Saigon, Research, Confession, Nightclub

CHICAGO, March 7, 2024 /PRNewswire/ -- Prepare for a night of pure Broadway magic as the stars align for the Pulmonary Fibrosis Foundation's (PFF) 14th annual Broadway Belts for PFF!

Key Points: 
  • CHICAGO, March 7, 2024 /PRNewswire/ -- Prepare for a night of pure Broadway magic as the stars align for the Pulmonary Fibrosis Foundation's (PFF) 14th annual Broadway Belts for PFF!
  • "The Broadway community stands together in solidarity with those affected by pulmonary fibrosis," said Julie Halston.
  • Since its inception, Broadway Belts for PFF!, has raised over $3 million for PF research and support programs.
  • To purchase tickets and for more information about Broadway Belts for PFF!, visit broadwaybeltsforpff.org .

Pulmonary Fibrosis Foundation Unveils Groundbreaking Research by PFF Scholars

Retrieved on: 
月曜日, 1月 22, 2024
ILD, Death, Health, Patient, Research, Fibrosis, PFF, Scholar, Scar, Idiopathic pulmonary fibrosis, Science, PET, Palliative care, Quality of life, Disorder, Pulmonary fibrosis, Disease, IPF, Inflammation, Boehringer Ingelheim, Coronavirus, Lung, Blood, Pharmaceutical industry

CHICAGO, Jan. 22, 2024 /PRNewswire-PRWeb/ -- The Pulmonary Fibrosis Foundation (PFF), the nation's leading pulmonary fibrosis research, advocacy, and education organization has announced five awardees for the 2023 cycle of PFF Scholars who will receive funding for their cutting-edge research. Each Scholar will receive a $100,000 research grant over a two-year period to improve the understanding of pulmonary fibrosis and lead to successful therapies in treating the disease.

Key Points: 
  • The Pulmonary Fibrosis Foundation has announced five PFF Scholars who will each receive a $100,000 grant to research key questions about pulmonary fibrosis.
  • CHICAGO, Jan. 22, 2024 /PRNewswire-PRWeb/ -- The Pulmonary Fibrosis Foundation (PFF), the nation's leading pulmonary fibrosis research, advocacy, and education organization has announced five awardees for the 2023 cycle of PFF Scholars who will receive funding for their cutting-edge research.
  • "The most recent PFF Scholars class is tackling some of the most urgent questions about pulmonary fibrosis," said Scott Staszak, PFF Chief Operating Officer.
  • The PFF aims to support projects that offer a high likelihood of improving the understanding of pulmonary fibrosis in the areas of basic science, translational research, clinical research, epidemiological research, and health services research.

Broadway Stars Take Center Stage in 14th Anniversary Benefit for Pulmonary Fibrosis

Retrieved on: 
水曜日, 1月 17, 2024
Cagney, The King, Family, Grammy Awards, The Music Man, Research, Confession, PFF, Scar, Sony Hall, City, Pulmonary fibrosis, Infant, Disease, Come, Music, Divinity, Nightclub

CHICAGO, Jan. 17, 2024 /PRNewswire/ -- A constellation of renowned Broadway stars is set to grace the stage for the Pulmonary Fibrosis Foundation's (PFF) 14th annual Broadway Belts for PFF!

Key Points: 
  • CHICAGO, Jan. 17, 2024 /PRNewswire/ -- A constellation of renowned Broadway stars is set to grace the stage for the Pulmonary Fibrosis Foundation's (PFF) 14th annual Broadway Belts for PFF!
  • The benefit concert promises an evening of unforgettable performances aimed at raising funds and awareness for the more than 250,000 Americans living with pulmonary fibrosis.
  • "Broadway stars are raising their voices in support of people with pulmonary fibrosis," said actress Julie Halston.
  • Broadway Belts for PFF!, the Pulmonary Fibrosis Foundation's single-largest fundraiser, has raised over $3 million to drive PF research and to support those living with the disease.

Pulmonary Fibrosis Foundation Aims to Bridge Healthcare Gaps in Rural Communities

Retrieved on: 
金曜日, 12月 22, 2023
Outline, Risk, Multimedia, Pulmonary fibrosis, Research, Telehealth, CMO, ILD, Idiopathic pulmonary fibrosis, Lung transplantation, IPF, Health, Incidence, PFF, Patient, Palliative care, Communication, Nursing

CHICAGO, Dec. 22, 2023 /PRNewswire-PRWeb/ -- The Pulmonary Fibrosis Foundation (PFF) has published a comprehensive position statement to increase awareness of pulmonary fibrosis (PF) in rural communities and to outline the Foundation's rural health initiatives. The "Rural Outreach in Pulmonary Fibrosis" statement, comprising versions tailored for patients and healthcare providers, delineates strategies impacting patient care, research, and advocacy.

Key Points: 
  • The Pulmonary Fibrosis Foundation's new position statement addresses rural healthcare gaps, focusing on raising awareness and offering resources for people living with pulmonary fibrosis and their healthcare providers.
  • CHICAGO, Dec. 22, 2023 /PRNewswire-PRWeb/ -- The Pulmonary Fibrosis Foundation (PFF) has published a comprehensive position statement to increase awareness of pulmonary fibrosis (PF) in rural communities and to outline the Foundation's rural health initiatives.
  • The "Rural Outreach in Pulmonary Fibrosis" statement, comprising versions tailored for patients and healthcare providers , delineates strategies impacting patient care, research, and advocacy.
  • "Residents in rural communities encounter significant obstacles to healthcare access, including distance to specialized centers, communication challenges between providers, and limitations in clinical information exchange.

IDEMIA to supply seamless Passenger Flow Facilitation solution at Airports Company South Africa (ACSA)

Retrieved on: 
木曜日, 12月 7, 2023
Changi Airport, African, Lyon–Saint-Exupéry Airport, PFF, Airport, ACSA, Digitization, DHA, Partnership, Atmosphere, Airports Company South Africa, ABIS, NIST, IDEMIA, Transport, Airline, Envelope (music)

RESTON, Va., Dec. 7, 2023 /PRNewswire/ -- IDEMIA, the global leader in identity technologies, is delighted to have been awarded by the Airports Company South Africa (ACSA) the deployment of its Passenger Flow Facilitation (PFF) solution in nine South African airports.

Key Points: 
  • RESTON, Va., Dec. 7, 2023 /PRNewswire/ -- IDEMIA, the global leader in identity technologies, is delighted to have been awarded by the Airports Company South Africa (ACSA) the deployment of its Passenger Flow Facilitation (PFF) solution in nine South African airports.
  • Interconnected with all the major airlines in the world, South Africa is a key country when it comes to air transportation in Africa.
  • "We are thrilled to be launching a new passenger facilitation solution at our nine ACSA airports, and for the first time in Southern Africa.
  • In line with our Sustain, Grow and Digitize strategy, this solution positions ACSA as the leading airports management services company in Africa."

Pulmonary Fibrosis Foundation's PFF Summit 2023 Advances Research

Retrieved on: 
木曜日, 12月 7, 2023
Vutrisiran, Extracellular matrix, Genetics, Research, Safety, Food, Travel, ILD, Nursing, Physician, Cystic Fibrosis Foundation, Boehringer Ingelheim, Risk, PFF, PFF Women's League, RN, Patient, Critical care, Virginia Commonwealth University, Medicine, Division, Collaboration, Accreditation, Birmingham School of Law, Caregiver, COVID-19, University, Summit, Vanderbilt University, Nursing care plan, Health care, Doctor of Philosophy, Columbia University, Knowledge, University of Wisconsin–Madison, Pulmonary fibrosis, Critical Care Medicine (journal), Drug development, History of Stanford Medicine, Pharmaceutical industry, Medical device, Certification, MD

CHICAGO, Dec. 7, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation's PFF Summit 2023, the world's largest pulmonary fibrosis (PF) and interstitial lung disease (ILD) conference, concluded its seventh biennial meeting on Nov. 11 in Orlando, Fla. Physicians and specialists from around the globe converged to share cutting-edge research, innovative treatment modalities, and real-world clinical experiences in combating PF and ILD. The conference, which took place Nov. 9-11, returned to its in-person format for the first time since 2019.

Key Points: 
  • CHICAGO, Dec. 7, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation's PFF Summit 2023, the world's largest pulmonary fibrosis (PF) and interstitial lung disease (ILD) conference, concluded its seventh biennial meeting on Nov. 11 in Orlando, Fla. Physicians and specialists from around the globe converged to share cutting-edge research, innovative treatment modalities, and real-world clinical experiences in combating PF and ILD.
  • Over three days, the PFF Summit brought together more than 800 healthcare experts, physicians, researchers, patients, caregivers, and industry leaders from 43 states and 16 countries in an exchange of knowledge, experiences, and insights on PF research and care.
  • Recordings from the PFF Summit 2023 will be available on-demand on our YouTube channel in the spring of 2024.
  • The next PFF Summit will be held at the Sheraton Grande Chicago Riverwalk in November 2025.

Avalyn Presents Data from its AP01 and AP02 Inhaled Therapeutics Programs for Pulmonary Fibrosis

Retrieved on: 
木曜日, 11月 9, 2023
Lazarus, Pulmonary fibrosis, Lake, HRCT, Idiopathic pulmonary fibrosis, IPF, FVC, Summit, OLE, Disease, Caregiver, ATLAS, ILD, Vital capacity, Safety, Patient, PFF, FCCP, Outline, Pharmaceutical industry

SEATTLE, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted inhalation therapies for life-threatening pulmonary diseases, today announced the presentation of preclinical data that supported the completed Phase 1a trial of AP02 (inhaled nintedanib) as well as clinical data for AP01 (inhaled pirfenidone) at the 2023 Pulmonary Fibrosis Foundation (PFF) Summit at the JW Marriott Grande Lakes in Orlando, FL.

Key Points: 
  • “We are excited to engage with the pulmonary fibrosis community at the PFF Summit, including people living with the disease, their caregivers and the expert providers that support them, and to share data for our inhaled treatment candidates AP01 and AP02,” said Howard M. Lazarus, M.D.
  • These data demonstrated that inhaled nintedanib was well-tolerated, was indicative of efficient inhaled alveolar deposition, and delivered oral-superior lung levels with reduced systemic exposure.
  • Avalyn will also review the results from the Phase 1b trial of AP01 (ATLAS) in participants with idiopathic pulmonary fibrosis (IPF).
  • The OLE enrolled ATLAS participants and AP01-naïve pulmonary fibrosis participants, and the data showed a durable and consistent response to AP01, including fewer reported adverse events compared to historical reports of oral pirfenidone.

Pulmonary Fibrosis Foundation and Pulmonary Hypertension Association Provide Guidance on Pulmonary Hypertension Related to Interstitial Lung Disease

Retrieved on: 
水曜日, 10月 25, 2023
Pulmonary hypertension, PHA, Pulmonary fibrosis, Health care, Pulmonary Hypertension Association, Lung transplantation, Cystic Fibrosis Foundation, Quality of life, Tissue, PF, Disease, Heart, Risk, PH, ILD, CMO, Patient, Diagnosis, PFF, Pharmaceutical industry, Medical imaging

CHICAGO, Oct. 25, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) and Pulmonary Hypertension Association have developed a position statement that addresses gaps in the screening, diagnosis and treatment of patients living with pulmonary hypertension (PH) related to interstitial lung disease (PH-ILD).

Key Points: 
  • CHICAGO, Oct. 25, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) and Pulmonary Hypertension Association have developed a position statement that addresses gaps in the screening, diagnosis and treatment of patients living with pulmonary hypertension (PH) related to interstitial lung disease (PH-ILD).
  • The PH-ILD position statement, featuring a version for patients and a version for healthcare providers, reflects input from experts in interstitial lung disease (ILD), PH, PH-ILD and patient representatives.
  • More than 250,000 Americans are living with pulmonary fibrosis (PF) and ILD.
  • PF, a form of ILD, can have many causes and they can all be associated with PH.

Pulmonary Fibrosis Foundation Expands Care Center Network for PF Patients

Retrieved on: 
木曜日, 10月 12, 2023
Diagnosis, Urgent care center, ILD, Inflammation, PF, Nursing, PFF, University, Pulmonary fibrosis, Clinical associates, Academic Medical Center (Amsterdam), Scar, Lung, CCN, San Diego, Patient, University of New Mexico, University of California, San Diego, Atmosphere

CHICAGO, Oct. 12, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced that seven medical centers have joined the PFF Care Center Network (CCN) as Clinical Associate members, a new membership option. Each of these Clinical Associates will collaborate with an existing Care Center Network site to help bring the resources of the PFF to even more people living with pulmonary fibrosis (PF) and interstitial lung disease (ILD). The Care Center Network includes 81 CCN sites and seven Clinical Associates in 39 states.

Key Points: 
  • CHICAGO, Oct. 12, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced that seven medical centers have joined the PFF Care Center Network (CCN) as Clinical Associate members, a new membership option.
  • Each of these Clinical Associates will collaborate with an existing Care Center Network site to help bring the resources of the PFF to even more people living with pulmonary fibrosis (PF) and interstitial lung disease (ILD).
  • The newly designated Clinical Associate members of the PFF Care Center Network are:
    Chest Medicine Associates Center for Interstitial Lung Disease (South Portland, ME): Dr. Meagan Moore, Center Director
    Ochsner LSU Health Shreveport – Academic Medical Center (Shreveport, LA): Dr. Prangthip Charoenpong, Center Director
    University of New Mexico (Albuquerque, NM): Dr. Nour Ass'ad, Center Director
    Through the CCN, Care Centers and Clinical Associates collaborate to promote and provide quality care to those living with PF.
  • Each Clinical Associate is paired with a current Care Center member so they may collaborate to expand and improve pulmonary fibrosis care.